b'DISCOVER THE CURRENTOF CALQUENCEFollow the current to the latest long-term efficacy and safety data,now with up to ~6 years of median follow-up* 1See the Latest Datafrom the 2023 ASH Annual MeetingSEE MORE INFORMATION ATcalquencehcp.com OR SCAN QR CODE*At median 74.5-month follow-up (range: 0.0-89.0 months). 1Reference: 1. Sharman JP, et al. Abstract 636. Presented at: 2023 ASH Annual Meeting. December 9-12.CALQUENCE is a registered trademark of the AstraZeneca group of companies. 2023 AstraZeneca. All rights reserved. US-80102 10/23US-80102 Calquence U.S. Medicine 2024 Directory of Federal Medical Treatment Facilities.indd 1 11/22/23 11:42 AM'